{"id":"811","post_author":null,"post_date":null,"post_date_gmt":null,"post_content":null,"post_title":"InVivoSIM anti-human GPNMB (Glembatumumab Biosimilar)","post_excerpt":"This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Glembatumumab, making it ideal for research use. Glembatumumab is a fully human IgG2 monoclonal antibody that targets glycoprotein non-metastatic melanoma protein B (GPNMB), a transmembrane glycoprotein overexpressed in various cancers, including triple-negative breast cancer (TNBC), melanoma, glioblastoma, and osteosarcoma. GPNMB is associated with tumor progression, metastasis, and poor prognosis. In therapeutic applications, Glembatumumab is conjugated to the cytotoxic agent monomethyl auristatin E (MMAE) to form the antibody-drug conjugate (ADC) Glembatumumab vedotin. This ADC binds to GPNMB-expressing tumor cells, is internalized, and releases MMAE intracellularly, leading to cell death. However, this biosimilar is unconjugated and formulated for non-therapeutic research use only, making it an excellent tool for studying GPNMB biology, tumor immunology, and the development of GPNMB-targeted therapies.\n","post_status":"publish","comment_status":null,"ping_status":null,"post_password":null,"post_name":"invivosim-anti-human-gpnmb-glembatumumab-biosimilar-sim0066","to_ping":null,"pinged":null,"post_modified":null,"post_modified_gmt":null,"post_content_filtered":null,"post_parent":null,"guid":null,"menu_order":null,"post_type":null,"post_mime_type":null,"comment_count":null,"filter":null,"sku":"SIM0066","path":"\/product\/invivosim-anti-human-gpnmb-glembatumumab-biosimilar-sim0066\/","image":"https:\/\/pneuma.bioxcell.com\/Media\/Products\/bioxcell-sim0066-invivosim-anti-human-gpnmb-glembatumumab-biosimilar.png","brand_id":null,"brand_name":null,"brand_slug":null,"brand_description":null,"isotype":"Human IgG2, \u03ba","immunogen":"Human GPNMB","reported_applications":"Functional assays\nFlow cytometry\nELISA\nImmunohistochemistry\nWestern blot","aggregation":"<5%\nDetermined by SEC","formulation":"PBS, pH 7.0\nContains no stabilizers or preservatives","murine_pathogen_tests":"Mouse Norovirus: Negative\nMouse Parvovirus: Negative\nMouse Minute Virus: Negative\nMouse Hepatitis Virus: Negative\nReovirus Screen: Negative\nLymphocytic Choriomeningitis virus: Negative\nLactate Dehydrogenase-Elevating Virus: Negative\nMouse Rotavirus: Negative\nTheiler's Murine Encephalomyelitis: Negative\nEctromelia\/Mousepox Virus: Negative\nHantavirus: Negative\nPolyoma Virus: Negative\nMouse Adenovirus: Negative\nSendai Virus: Negative\nMycoplasma Pulmonis: Negative\nPneumonia Virus of Mice: Negative\nMouse Cytomegalovirus: Negative\nK Virus: Negative","human_pathogen_tests":"","toxicity_test_results":null,"endotoxin":"<ul><li>\u22640.5EU\/mg (\u22640.0005EU\/\u03bcg)<\/li><li>Determined by LAL gel clotting assay<\/li><\/ul>","purity":"<ul><li>\u226595%<\/li><li>Determined by SDS-PAGE<\/li><\/ul>","sterility":"0.2 \u03bcm filtration","production":"Purified from cell culture supernatant in an animal-free facility","purification":"Protein A","composition":null,"volume":null,"concentration":null,"molecular_weight":"150 kDa","storage":"The antibody solution should be stored at the stock concentration at 4\u00b0C. Do not freeze.","rrid":"","recommended_isotype_control":"<a href=\"\/product\/\">RecombiMAb human IgG2 isotype control, anti-hen egg lysozyme<\/a>","recommended_dilution_buffer":"<a href=\"\/product\/\">InVivoPure pH 7.0 Dilution Buffer<\/a>","clone":"Glembatumumab","technical_data_sheet":"https:\/\/pneuma.bioxcell.com\/api\/v1\/products\/certificate-of-analysis\/SIM0066\/0\/0\/0?apikey=23D50188E6F74755AFFBF95BD41B140B","western_blot_image":null,"new_product_image":null,"product_references":null,"display_pubmed_logo":null,"modified":"2026-03-18 02:10:05","active":"Y"}

InVivoSIM anti-human GPNMB (Glembatumumab Biosimilar)

Clone	Catalog #	Category
Glembatumumab	SIM0066

USD 235 - USD 8140

Technical Data Sheet

SDS Sheet

About InVivoSIM anti-human GPNMB (Glembatumumab Biosimilar)

This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Glembatumumab, making it ideal for research use. Glembatumumab is a fully human IgG2 monoclonal antibody that targets glycoprotein non-metastatic melanoma protein B (GPNMB), a transmembrane glycoprotein overexpressed in various cancers, including triple-negative breast cancer (TNBC), melanoma, glioblastoma, and osteosarcoma. GPNMB is associated with tumor progression, metastasis, and poor prognosis. In therapeutic applications, Glembatumumab is conjugated to the cytotoxic agent monomethyl auristatin E (MMAE) to form the antibody-drug conjugate (ADC) Glembatumumab vedotin. This ADC binds to GPNMB-expressing tumor cells, is internalized, and releases MMAE intracellularly, leading to cell death. However, this biosimilar is unconjugated and formulated for non-therapeutic research use only, making it an excellent tool for studying GPNMB biology, tumor immunology, and the development of GPNMB-targeted therapies.

InVivoSIM anti-human GPNMB (Glembatumumab Biosimilar) Specifications

Isotype	Human IgG2, κ
Recommended Isotype Control(s)	RecombiMAb human IgG2 isotype control, anti-hen egg lysozyme
Recommended Dilution Buffer	InVivoPure pH 7.0 Dilution Buffer
Immunogen	Human GPNMB
Reported Applications	Functional assays Flow cytometry ELISA Immunohistochemistry Western blot
Formulation	PBS, pH 7.0 Contains no stabilizers or preservatives
Endotoxin	≤0.5EU/mg (≤0.0005EU/μg) Determined by LAL gel clotting assay
Aggregation	<5% Determined by SEC
Purity	≥95% Determined by SDS-PAGE
Sterility	0.2 μm filtration
Production	Purified from cell culture supernatant in an animal-free facility
Purification	Protein A
Molecular Weight	150 kDa
Storage	The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.